相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存:
大量供应
- 供应商:
康朗生物
- 检测范围:
详见说明书
- 检测方法:
夹心法
- 应用:
ELISA 定量检测
- 标记物:
详见说明书
- 样本:
血清,血浆,尿液 细胞裂解液,组织匀浆,细胞培养上清液
- 规格:
96T/盒
Human Peroxisome Proliferator Activated Receptor Gamma (PPARg) ELISA Kit
| Product name: | Human Peroxisome Proliferator Activated Receptor Gamma (PPARg) ELISA Kit |
| Method: | sandwich |
| Synonyms: | PPAR-G; PPARG1; PPARG2; NR1C3; Glitazone Receptor; Nuclear Receptor Subfamily 1 Group C Member 3 |
| Catalog number: | DL-PPARg-Hu |
| Detection range: | 0.156-10ng/mL |
| Size: | 96T |
| Assay length | 1-4.5Hours |
| Price: | inquiry |
| Quality guarantee period: | for 12 months |
Introduction
Human Peroxisome Proliferator Activated Receptor Gamma (PPARg) ELISA Kit
| Item | Standard | Test Result | |
| Description | This immunoassay kit allows for the specific measurement of this index in serum, Plasma , Urine ,tissue homogenates and Cell culture supernates and Other biological fluids.. |
Conform | |
| Identification | Colorimetric | Positive | |
| Composition | Pre-coated, ready to use 96-well strip plate Standard (freeze dried) Standard Diluent Detection Reagent A Detection Reagent B Assay Diluent A Assay Diluent B TMB Substhumane Stop Solution Wash Buffer(30 x concenthumane) Plate sealer for 96 wells Instruction manual |
1 2 1 × 20ml 1× 120μl 1× 120μl 1 × 12ml 1 × 12ml 1 × 9ml 1 ×6ml 1 ×20ml 2 1 |
Conform |
Human Peroxisome Proliferator Activated Receptor Gamma (PPARg) ELISA Kit
Test principle
The microtiter plate provided in this kit has been pre-coated with an antibody specific to this index. Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated polyclonal antibody preparation specific for this index and Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then a TMB substrate solution is added to each well. Only those wells that contain the index, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of a sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The concentration of the index in the samples is then determined by comparing the O.D. of the samples to the standard curve
Recovery
Matrices listed below were spiked with certain level of recombinant the index and the recovery humanes were calculated by comparing the measured value to the expected amount of the index in samples.
| Matrix | Recovery range (%) | Average(%) |
| serum(n=5) | 81-93 | 86 |
| EDTA plasma(n=5) | 80-97 | 88 |
| heparin plasma(n=5) | 90-101 | 95 |
Human Peroxisome Proliferator Activated Receptor Gamma (PPARg) ELISA Kit
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concenthumanion of the index and their serial dilutions. The results were demonsthumaned by the percentage of calculated concenthumanion to the expected.
| Sample | 1:2 | 1:4 | 1:8 | 1:16 |
| serum(n=5) | 82-96% | 83-98% | 81-99% | 93-101% |
| EDTA plasma(n=5) | 88-101% | 86-95% | 90-102% | 80-93% |
| heparin plasma(n=5) | 80-91% | 82-90% | 95-104% | 79-95% |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level the index were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level the index were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37℃;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 1 hour at 37℃;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 15-25 minutes at 37℃;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
DL-CGRP-Hu 人降钙素基因相关肽(CGRP) ELISA Kit human Calcitonin Gene Related Peptide (CGRP) ELISA Kit Homo sapiens human 12.35-1000pg/mL 4.26pg/mL 96T 3180 12 months
DL-CGRP-Ra 大鼠降钙素基因相关肽(CGRP) ELISA Kit Rat Calcitonin Gene Related Peptide (CGRP) ELISA Kit Rattus norvegicus Rat 12.35-1000pg/mL 4.86pg/mL 96T 3800 12 months
DL-CGRP-Mu 小鼠降钙素基因相关肽(CGRP) ELISA Kit mouse Calcitonin Gene Related Peptide (CGRP) ELISA Kit Mus musculus mouse 12.35-1000pg/mL 4.22pg/mL 96T 3260 12 months
DL-CA1-Hu 人碳酸酐酶Ⅰ(CA1) ELISA Kit human Carbonic Anhydrase I (CA1) ELISA Kit Homo sapiens human 1.563-100ng/mL 0.58ng/mL 96T 3530 12 months
DL-CA1-Mu 小鼠碳酸酐酶Ⅰ(CA1) ELISA Kit mouse Carbonic Anhydrase I (CA1) ELISA Kit Mus musculus mouse 0.781-50 IU/mL 0.3 IU/mL 96T 3620 12 months
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PPAR/ Agonist Increases the Expression of PGE2 Receptor Subtype EP4 in Human Lung Carcinoma Cells
. Peroxisome proliferator-activated receptor beta/ delta (PPARβ/δ), one of the nuclear hormone ligand-dependent transcription factors, has recently been reported to be involved in tumorigeniCity. We have shown that NSCLC cells express PPARβ/δ protein
Capture and Qualitative Analysis of the Activated Fc Receptor Complex from Live Cells
the isolation of activated Fc receptor complexes from RAW 264.7 macrophages using live?cell affinity receptor chromatography (LARC). The Fc receptor complex is activated and captured by IgG?coated microbeads on the surface of live macrophages. After the cells
. A new drug candidate belonging to the family of the peroxisome proliferator-activated receptor-delta agonists termed GW1516 (also referred to as GW501516) has been prohibited by the World Anti-Doping Agency in 2009
技术资料暂无技术资料 索取技术资料









